01676nam 22004335 450 991025455450332120200703085121.03-319-08982-X10.1007/978-3-319-08982-9(CKB)3710000000726801(DE-He213)978-3-319-08982-9(MiAaPQ)EBC4543255(PPN)194380343(EXLCZ)99371000000072680120160607d2016 u| 0engurnn|008mamaatxtrdacontentcrdamediacrrdacarrierHandbook of Incretin-based Therapies in Type 2 Diabetes /edited by Stephen Gough1st ed. 2016.Cham :Springer International Publishing :Imprint: Adis,2016.1 online resource (IX, 92 p. 20 illus., 16 illus. in color.) 3-319-08981-1 Includes bibliographical references at the end of each chapters.Introduction and disease overview -- Incretin hormones as a target for therapy -- Glucagon-like peptide receptor agonists -- Dipeptidyl peptidase-4 inhibitors -- Global position and recommendations for use -- Future and emerging therapies. . .DiabetesDiabeteshttps://scigraph.springernature.com/ontologies/product-market-codes/H33045Diabetes.Diabetes.616.462616.46Gough Stephenedthttp://id.loc.gov/vocabulary/relators/edtBOOK9910254554503321Handbook of Incretin-based Therapies in Type 2 Diabetes2540564UNINA